TrialCancer research and treatment2019

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.

Youjin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.